Policy | September 11, 2023
G20 New Delhi Leaders' Declaration on strengthening global health
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
This approval has come from the company's finished dosage form manufacturing facility
Meningitis still affects more than 2.5 million people globally each year
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
